tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Luca Issi, 86 are a HOLD (39.81%), 129 are a BUY (59.72%), 1 are a SELL (0.46%).
Analyst Luca Issi, currently employed at RBC, carries an average stock price target met ratio of 30.62% that have a potential upside of 29.48% achieved within 114 days.
Luca Issi’s has documented 424 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 04-Sep-2025.
Analyst best performing recommendations are on FDMT (4D MOLECULAR THERAPEUTICS ).
The best stock recommendation documented was for FDMT (4D MOLECULAR THERAPEUTICS ) at 1/29/2024. The price target of $25 was fulfilled within 7 days with a profit of $6.98 (38.73%) receiving and performance score of 55.34.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
1 months 13 days ago
(04-Aug-2025)
0/3 (0%)
$2.86 (55.64%)
Hold
$5
1 months 13 days ago
(04-Aug-2025)
1/9 (11.11%)
$3.06 (157.73%)
148
Buy
$10
$8.87 (784.96%)
4 months 3 days ago
(14-May-2025)
2/10 (20%)
$9.05 (952.63%)
94
Buy
$9
$7.87 (696.46%)
$10
4 months 3 days ago
(14-May-2025)
0/3 (0%)
$8.05 (847.37%)
Buy
$7
$5.87 (519.47%)
$9
4 months 3 days ago
(14-May-2025)
2/9 (22.22%)
$6.05 (636.84%)
3
Which stock is Luca Issi is most bullish on?
Which stock is Luca Issi is most reserved on?
What Year was the first public recommendation made by Luca Issi?
